Loading…
GE HealthCare Technologies Inc. is projected to rise to $77.30 by 2027, a +21% move from its current price of $64.11. GEHC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/29/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 31 | $62.87 | $64.13 | $65.42 | +0.03% |
| Aug 1 | $62.38 | $64.15 | $65.98 | +0.07% |
| Aug 2 | $62.01 | $64.18 | $66.42 | +0.10% |
| Aug 3 | $61.70 | $64.20 | $66.80 | +0.14% |
| Aug 4 | $61.43 | $64.22 | $67.14 | +0.17% |
| Aug 5 | $61.19 | $64.24 | $67.44 | +0.20% |
| Aug 6 | $60.97 | $64.26 | $67.73 | +0.24% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $60.97 | $64.26 | $67.73 | +0.24% |
| Week 2 | $59.80 | $64.42 | $69.38 | +0.48% |
| Week 3 | $58.95 | $64.57 | $70.72 | +0.72% |
| Week 4 | $58.27 | $64.72 | $71.89 | +0.95% |
| Week 5 | $57.68 | $64.88 | $72.96 | +1.19% |
| Week 6 | $57.18 | $65.03 | $73.96 | +1.44% |
| Week 7 | $56.72 | $65.18 | $74.91 | +1.68% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).
The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products.
The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries; and contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes.
The company was incorporated in 2022 and is headquartered in Chicago, Illinois. It was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company has a strategic collaboration with DeepHealth.
GE HealthCare Technologies Inc. (GEHC) is trading at $61.41 with a market cap of $27.93B, ranking 457. The stock carries BEARISH sentiment and has an RSI14 of 40, trading below its 50-day SMA of $63.54 and well below the 200-day SMA of $73.40.
The 30-day range is $54.28 to $69.48, with near-term support at $60.64 and resistance at $66.01. The current price sits near support, indicating limited near-term upside momentum. The long-range forecast outlines a bullish price path across the coming years, with year-by-year averages and ROIs that project meaningful upside into 2050.
A major floor 9.1% below — a decisive break under it would weaken the trend.
The nearest floor, 5.5% below — buyers have tended to step in here.
Price is pressing into resistance (2.6% away) — a breakout level to watch.
A major ceiling 16.5% above — clearing it would confirm fresh momentum.
Key GEHC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GEHC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $61.84 | Buy | $62.40 | Buy |
| MA 10 | $62.61 | Buy | $62.59 | Buy |
| MA 20 | $63.56 | Buy | $63.09 | Buy |
| MA 50 | $63.52 | Buy | $64.22 | Sell |
| MA 100 | $66.46 | Sell | $66.88 | Sell |
| MA 200 | $73.12 | Sell | $70.46 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.63 | Neutral |
| Stoch RSI (14) | 84.49 | Sell |
| CCI (20) | 25.72 | Neutral |
| Williams %R (14) | -31.05 | Info |
| MACD (12,26,9) | -0.14 | Sell |
| ROC (12) | -0.91 | Sell |
| Bollinger %B (20,2) | 0.59 | Neutral |
| Stochastic %K (14) | 68.95 | Neutral |
| TRIX (15) | -0.08 | Sell |
| Awesome (5,34) | -1.88 | Sell |
| Ultimate (7,14,28) | 53.89 | Neutral |
| Momentum (10) | 2.45 | Buy |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 61.46 | Buy |
| ADX (14) | 10.95 | Neutral |
| ATR (14) | 1.16 | Info |
In the near term, the technical picture shows bearish momentum. The RSI14 is 40, and the price is trading below the 50-day SMA ($63.54) and the 200-day SMA ($73.40). Near-term levels to watch include support at $60.64 and resistance at $66.01, with the 30-day trading range spanning $54.28 to $69.48.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $59.49 | $64.11 | $84.36 | 0% | Neutral | |
| $63.17 | $77.30 | $99.01 | +21% | Bullish | |
| $70.55 | $88.08 | $116.06 | +37% | Bullish | |
| $81.92 | $103.95 | $140.06 | +62% | Bullish | |
| $93.37 | $120.19 | $165.02 | +87% | Bullish | |
| $94.83 | $123.66 | $172.59 | +93% | Bullish | |
| $98.63 | $130.17 | $184.40 | +103% | Bullish | |
| $105.74 | $141.12 | $202.62 | +120% | Bullish | |
| $108.75 | $146.67 | $213.24 | +129% | Bullish | |
| $127.91 | $174.26 | $256.29 | +172% | Bullish | |
| $161.39 | $229.96 | $355.17 | +259% | Bullish | |
| $334.09 | $513.08 | $851.84 | +700% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $59.49 | $64.11 | $74.84 | +0.00% |
| August 2026 | $55.46 | $64.75 | $77.10 | +0.99% |
| September 2026 | $56.31 | $66.13 | $79.50 | +2.13% |
| October 2026 | $55.73 | $65.76 | $79.67 | -0.55% |
| November 2026 | $55.89 | $66.21 | $80.72 | +0.68% |
| December 2026 | $57.87 | $68.80 | $84.36 | +3.91% |
Click any year to see its month-by-month GEHC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect GEHC to range from $59.49 to $84.36 through 2026. The $64.11 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The GEHC price prediction for 2027 points to an average of $77.30 (low $63.17, high $99.01) — a potential gain of +21% on today's $64.11. Buyers look set to stay in control over this stretch.
In 2028, GEHC is projected to trade between $70.55 and $116.06, averaging $88.08 — a potential gain of +37% from today's $64.11. That is up +14% on the projected 2027 average. Momentum favours further upside here.
GE HealthCare Technologies Inc.'s 2029 outlook centres on $103.95, within a $81.92 to $140.06 range. That is up +18% on the projected 2028 average. That marks a +62% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, GEHC could reach as high as $165.02, with a base case around $120.19 and support toward $93.37 — roughly +87% from $64.11. Momentum favours further upside here.
Expect GEHC to range from $94.83 to $172.59 through 2031. The $123.66 average target implies a +93% move from current prices. That is up +3% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The GEHC price prediction for 2032 points to an average of $130.17 (low $98.63, high $184.40) — a potential gain of +103% on today's $64.11. Momentum favours further upside here.
In 2033, GEHC is projected to trade between $105.74 and $202.62, averaging $141.12 — a potential gain of +120% from today's $64.11. That is up +8% on the projected 2032 average. Buyers look set to stay in control over this stretch.
GE HealthCare Technologies Inc.'s 2034 outlook centres on $146.67, within a $108.75 to $213.24 range. That is up +4% on the projected 2033 average. That marks a +129% change versus current levels. Momentum favours further upside here.
By 2035, GEHC could reach as high as $256.29, with a base case around $174.26 and support toward $127.91 — roughly +172% from $64.11. Buyers look set to stay in control over this stretch.
Expect GEHC to range from $161.39 to $355.17 through 2040. The $229.96 average target implies a +259% move from current prices. That is up +32% on the projected 2035 average. Momentum favours further upside here.
The GEHC price prediction for 2050 points to an average of $513.08 (low $334.09, high $851.84) — a potential gain of +700% on today's $64.11. Buyers look set to stay in control over this stretch.
Investing $1,000 in GEHC today (≈ 15.598191 GEHC) could be worth
$8,003.09
+$7,003.09 (+700%) by 2050 · US Dollar
Based on the average projected GEHC price of $513.08 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GEHCwould be worth at today's price.
$1,000 invested in GEHC on Jul 28, 2025 (≈ 12.863391 GEHC) would be worth
$824.67
-$175.33 (-17.5%) today · 0.82× · US Dollar
Based on a GEHC entry price of $77.74 vs. today's $64.11.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $62.04 | $1,033.37 | +3.3% |
| 1 month ago | $65.05 | $985.55 | -1.4% |
| 3 months ago | $59.49 | $1,077.75 | +7.8% |
| 6 months ago | $78.78 | $813.79 | -18.6% |
| 1 year ago | $77.74 | $824.67 | -17.5% |
| All time (3.6y) ago | $60 | $1,068.5 | +6.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GEHC forecast.
Our base-case forecast reaches $130.00 around 2032.
Implied market cap at $130.00: $59.14B
The multi-year forecast points to a bullish trajectory through 2030 and beyond. The 2026 average price is $61.41 with a min of $59.49 and a max of $80.84 and ROI of 0; by 2027 the average rises to $72.62 (ROI 18.3), and by 2028 to $82.71 (ROI 34.7). The 2029 average is $97.32 (ROI 58.5), and the 2030 average reaches $111.12 (ROI 81).
Subsequent years show continued growth: 2031 $114.36 (ROI 86.2), 2032 $119.78 (ROI 95.1), 2033 $128.71 (ROI 109.6), 2034 $133.96 (ROI 118.2), and 2035 $157.82 (ROI 157).
Looking further out, 2040 delivers an average of $206.29 (ROI 235.9) and 2050 an average of $455.41 (ROI 641.6). Across these horizons, the sentiment shifts to BULLISH, though volatility remains a consideration given the historical level of price movement. These figures are estimates, not guarantees, and depend on future market conditions and other factors.
Tap a question to reveal the answer.
The forecast shows an average price of $111.12, with a min of $86.83 and a max of $151.39, and an ROI of 81. The sentiment is BULLISH.
Long-run forecasts show a bullish trajectory with higher average prices through 2030, 2040, and 2050 and ROIs of 81, 235.9, and 641.6 respectively. Near term, the sentiment is NEUTRAL or BEARISH, and the current price is $61.41 with a 30-day range of $54.28 to $69.48; forecasts are not guarantees.
Yes. The 2040 forecast lists an average price of $206.29 and a max of $314.58, with a min of $146.53, indicating the possibility of exceeding $200 in that period.
Bearish sentiment with RSI14 of 40. The stock trades with a 50-day SMA of $63.54 and a 200-day SMA of $73.40. Support is at $60.64 and resistance at $66.01, and the 30-day range is $54.28 to $69.48.
Current price is $61.41 and market cap is $27.93B, with an overall rank of 457.
GE HealthCare Technologies Inc. Community Discussion
0Share your GE HealthCare Technologies Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.